business
Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026
Key takeaways
- Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026 Fahad Saleem Mon, June 8, 2026 at 9:29 PM GMT+7 2 min read NAMS We just covered the
- 10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller.
- Druckenmiller likes asymmetric bets where he can risk a small position for potentially large upside.
Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026 Fahad Saleem Mon, June 8, 2026 at 9:29 PM GMT+7 2 min read NAMS We just covered the
10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. New Amsterdam Pharma Company N.V. (NASDAQ:NAMS) ranks #5 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller).
Druckenmiller likes asymmetric bets where he can risk a small position for potentially large upside. NAMS falls in this category. It’s a Netherlands-based biotech developing obicetrapib, an oral drug designed to lower bad cholesterol. The product is targeted towards people who are not able to reach target levels even after taking standard treatments like statins.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop